Obstructive sleep apnea and cardiovascular disease: Evidence and underlying mechanisms

Minerva Pneumologica

Volumn 48, Issue 4, 2009, Pages 277-293

  Jean Louis, G ^a,b,c   Zizi, F ^a,b,c   Brown, C D ^b   Ogedegbe, G ^d   Borer, J S ^b   McFarlane, S I ^a  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

^b SUNY Downstate Medical Center   (United States)

^c Brooklyn Research Foundation on Minority Health   (United States)

^d NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Cardiovascular diseases; Diabetes mellitus; Hypertension; Obesity; Sleep apnea, obstructive

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ANTIHYPERTENSIVE THERAPY; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; CONGESTIVE HEART FAILURE; CORONARY ARTERY DISEASE; DENTAL DEVICE; DEVICE THERAPY; DIABETES MELLITUS; DISEASE ASSOCIATION; DYSLIPIDEMIA; EVIDENCE BASED MEDICINE; HEART ARRHYTHMIA; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE ISCHEMIA; HUMAN; HYPERTENSION; METABOLIC SYNDROME X; OBESITY; PATHOPHYSIOLOGY; POLYSOMNOGRAPHY; POSITIVE END EXPIRATORY PRESSURE; PREVALENCE; REVIEW; SLEEP APNEA SYNDROME; STROKE; THROMBOCYTE ACTIVATION; UVULOPALATOPHARYNGOPLASTY;

EID: 77949499077     PISSN: 00264954     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (100)

1. Coccagna G, Mantovani M, Brignani F, Parchi C, Lugaresi E. Tracheostomy in hypersomnia with periodic breathing. Bull Physiopathol Respir 1972;8:1217-27.
2. Coccagna G, Mantovani M, Brignani F, Parchi C, Lugaresi E. Continuous recording of the pulmonary and systemic arterial pressure during sleep in syndromes of hypersomnia with periodic breathing. Bull Physiopathol Respir 1972;8:1159-72.
3. Hedner J, Ejnell H, Sellgren J, Hedner T, Wallin G. Is high and fluctuating muscle nerve sympathetic activity in the sleep apnoea syndrome of pathogenetic importance for the development of hypertension? J Hypertens Suppl 1988;6:S529-S31.
4. Stoohs RA, Guilleminault C, Itoi A, Dement WC. Traffic accidents in commercial long-haul truck drivers: the influence of sleep-disordered breathing and obesity. Sleep 1994;17:619-23.
5. El Ad B, Lavie P. Effect of sleep apnea on cognition and mood. Int Rev Psychiatry 2005;17:277-82.
6. Sharafkhaneh A, Giray N, Richardson P, Young T, Hirshkowitz M. Association of psychiatric disorders and sleep apnea in a large cohort. Sleep 2005;28:1405-11.
7. Punjabi NM, Caffo BS, Goodwin JL, Gottlieb DJ, Newman AB, O'Connor GT et al. Sleep-disordered breathing and mortality: a prospective cohort study. PLoS Med 2009;6:e1000132.
8. Young T, Finn L. Epidemiological insights into the public health burden of sleep disordered breathing: sex differences in survival among sleep clinic patients. Thorax 1998;53(Suppl 3):S16-S9.
9. The National Commission on Sleep Disorders Research. [Accessed on 2002 August 8; cited 2009 November 5]. Available at: http://www.stanford.edu/~dement/ overview-ncsdr.html.
10. Young T, Peppard P, Palta M, Hla KM, Finn L, Morgan B et al. Population-based study of sleep-disordered breathing as a risk factor for hypertension. Arch Intern Med 1997;157:1746-52.
11. Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurrence of sleep-disordered breathing among middle-aged adults [see comments]. N Engl J Med 1993;328:1230-5.
12. Schechter MS. Technical report: diagnosis and management of childhood obstructive sleep apnea syndrome. Pediatrics 2002;109:e69.
13. Ancoli-Israel S, Kripke DF, Klauber MR, Mason WJ, Fell R, Kaplan O. Sleep-disordered breathing in community-dwelling elderly. Sleep 1991;14:496-500.
14. Meetze K, Gillespie MB, Lee FS. Obstructive sleep apnea: a comparison of black and white subjects. Laryngoscope 2002;112:1271-4.
15. Redline S, Tishler P, Hans M, Tosteson T, Strohl K, Spry K. Racial differences in sleep-disordered breathing in African-Americans and Caucasians. Am J Respir Crit Care Med 1997;155:186-92.
16. Jean-Louis G, Zizi F, von Gizycki H, Dharawat A., Lazar J, Brown C. Evaluation of Sleep Apnea in a Sample of Black Patients. J Clin Sleep Med 2008;15:421-5.
17. Jung R. Physiology and pathophysiology of sleep]. Med Welt 1965;24:1358-9.
18. Badr MS, Kawak A, Skatrud JB, Morrell MJ, Zahn BR, Babcock MA. Effect of induced hypocapnic hypopnea on upper airway patency in humans during NREM sleep. Respir Physiol 1997;110:33-45.
19. Remmers JE, Launois S, Feroah T, Whitelaw WA. Mechanics of the pharynx in patients with obstructive sleep apnea. Prog Clin Biol Res 1990;345:261-8.
20. Guilleminault C, Tilkian A, Dement WC. The sleep apnea syndromes. Annu Rev Med 1976;27:484.
21. Rechtshaffen A, Kales A. A manual of standardized terminoly, techniques, and scoring systems of sleep stages of human subjects. Los Angeles: UCLA Brain Information Service/Brain Research Institute 1968;10.
22. Chesson AL Jr, Ferber RA, Fry JM, Grigg-Damberger M, Hartse KM, Hurwitz TD et al. The indications for polysomnography and related procedures. Sleep 1997;20:423-87.
23. Kryger MH, Roth T, Dement WC. MDPrinciples and Practice of Sleep Medicine. 3rd ed. New York, NY: W B Saunders Co; 2002.
24. Stepnowsky CJ, Palau JJ, Gifford AL, Ancoli-Israel S. A self-management approach to improving continuous positive airway pressure adherence and outcomes. Behav Sleep Med 2007;5:131-46.
25. Strobel RJ, Rosen RC. Obesity and weight loss in obstructive sleep apnea: a critical review. Sleep 1996;19:104-15.
26. The American Academy of Sleep Medicine (Practice Parameters). [Accessed 2008 August 24; cited 2009 November 5]. Available at: http://www.aasmnet.org/ PracticeParameters.aspx
27. Wright J, Johns R, Watt I, Melville A, Sheldon T. Health effects of obstructive sleep apnoea and the effectiveness of continuous positive airways pressure: a systematic review of the research evidence. BMJ 1997;314:851-60.
28. Rosenthal L, Gerhardstein R, Lumley A, Guido P, Day R, Syron ML et al. CPAP therapy in patients with mild OSA: implementation and treatment outcome. Sleep Med 2000;1:215-20.
29. Phillipson EA. Sleep apnea - a major public health problem. N Engl J Med 1993;328:1271-3.
30. Report of the Scientific Committee on tobacco and health. [Accessed 2008 August 5; cited 2009 November 51. Available at: http://www.dh.gov.uk/en/ FreedomOfInformation/Freedomofinformationpublicationschemefeedback/FOIreleases/ DH-4131889.
31. The National Commission on Sleep Disorders Research. Wake up America: a national sleep alert. Washington, DC: US Government Printing Office; 2002.
32. Mehra R, Benjamin EJ, Shahar E, Gottlieb DJ, Nawabit R, Kirchner HL et al. Association of Nocturnal Arrhythmias with Sleep-Disordered Breathing: The Sleep Heart Health Study. Am J Respir Crit Care Med 2006;173:910-6.
33. Somers VK, White DP, Amin R, Abraham WT, Costa F, Culebras A et al. Sleep apnea and cardiovascular disease: an American Heart Association/American College of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council on Cardiovascular Nursing. J Am Coll Cardiol 2008;52:686-717.
34. Partinen M, Guilleminault C. Evolution of obstructive sleep apnea syndrome. In: Partinen M, Guilleminault C, editors. Obstructive sleep apnea syndrome. New York, NY: Raven Press; 1990. p. 15-23.
35. Guilleminault C, Connolly SJ, Winkle RA. Cardiac arrhythmia and conduction disturbances during sleep in 400 patients with sleep apnea syndrome. Am J Cardiol 1983;52:490-4.
36. Hoffstein V, Mateika S. Cardiac arrhythmias, snoring, and sleep apnea. Chest 1994;106:466-71.
37. Stradling J. Sleep Apnea Does Not Cause Cardiovascular Disease. Am J Respir Crit Care Med 2004;169:148-9.
38. Kiely JL, McNicholas WT, Zgierska A, Gorecka D, Radzikowska M, Baranowska B et al. Cardiovascular risk factors in patients with obstructive sleep apnoea syndrome. Eur Respir J 2000;16:128-33.
39. Yaggi HK, Concato J, Kernan WN, Lichtman JH, Brass LM, Mohsenin V. Obstructive sleep apnea as a risk factor for stroke and death. N Engl J Med 2005;353:2034-41.
40. Aartz M, Young T, Finn L, Skatrud JB, Bradley D. Association of sleep-disordered breathing and the occurence of stroke. Am J Respir Crit Care Med 2005;172:1447-51.
41. Brooks D, Horner RL, Render-Teixeira CL, Phillipson EA. Obstructive sleep apnea as a cause of systemic hypertension: evidence from a canine model. J Clin Invest 1997;99:109.
42. Somers VK, Garni AS, Olson LJ. Treating sleep apnea in heart failure patients: promises but still no prizes. J Am Coll Cardiol 2005;45:2012-4.
43. Borer J. Heart rate: from risk marker to risk factor. Eur Heart J 2008;10:F2-F6.
44. Shahar E, Whitney CW, Redline S, Lee ET, Newman AB, Javier NF et al. Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med 2001;163:19-25.
45. Garni AS, Pressman G, Caples SM. Association of atrial fibrillation and obstructive sleep apnea. Circulation 2004;27:367.
46. Shepard JW Jr, Garrison MW, Grither DA, Evans R, Schweitzer PK. Relationship of ventricular ectopy to nocturnal oxygen desaturation in patients with chronic obstructive pulmonary disease. Am J Med 1985;78:28-34.
47. Dyken ME, Somers VK, Yamada T, Ren ZY, Zimmerman MB. Investigating the relationship between stroke and obstructive sleep apnea. Stroke 1996;27:401-7.
48. Ip MS, Lam B, Chan LY, Zheng L, Tsang KW, Fung PC et al. Circulating nitric oxide is suppressed in obstructive sleep apnea and is reversed by nasal continuous positive airway pressure. Am J Respir Crit Care Med 2000;162:2166-71.
49. Lavie L. Obstructive sleep apnoea syndrome-an oxidative stress disorder. Sleep Med Rev 2003;7:35-51.
50. Kasasbeh E, Chi DS, Krishnaswamy G. Inflammatory aspects of sleep apnea and their cardiovascular consequences. South Med J 2006;99:58-67.
51. Lavie L. Sleep-disordered breathing and cerebrovascular disease: a mechanistic approach. Neurol Clin 2005;23:1059-75.
52. Yokoe T, Minoguchi K, Matsuo H, Oda N, Minoguchi H, Yoshino G et al. Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. Circulation 2003;107:1129-34.
53. Ishida K, Kato M, Kato Y, Yanagihara K, Kinugasa Y, Kotani K et al. Appropriate use of nasal continuous positive airway pressure decreases elevated C-reactive protein in patients with obstructive sleep apnea. Chest 2009;136:125-9.
54. Brown G, Albers JJ, Fisher LD, Schaefer SM, Lin JT, Kaplan C et al. Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B. N Engl J Med 1990;323:1289-98.
55. Kaneko Y, Floras JS, Usui K, Plante J, Tkacova R, Kubo T et al. Cardiovascular effects of continuous positive airway pressure in patients with heart failure and obstructive sleep apnea. N Engl J Med 2003;348:1233-41.
56. Malone S, Liu PP, Holloway R, Rutherford R, Xie A, Bradley TD. Obstructive sleep apnoea in patients with dilated cardiomyopathy: effects of continuous positive airway pressure. Lancet 1991;338:1480-4.
57. Somers VK, Dyken ME, Clary MP, Abboud FM. Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest 1995;96:1897-904.
58. Buchner NJ, Sanner BM, Borgel J, Rump LC. Continuous positive airway pressure treatment of mild to moderate obstructive sleep apnea reduces cardiovascular risk. Am J Respir Crit Care Med 2007;176:1274-80.
59. Fletcher EC. Cardiovascular effects of continuous positive airway pressure in obstructive sleep apnea. Sleep 2000;23(Suppl 4):S154-S7.
60. Parish JM, Adam T, Facchiano L. Relationship of metabolic syndrome and obstructive sleep apnea. J Clin Sleep Med 2007;3:467-72.
61. Dorkova Z, Petrasova D, Molcanyiova A, Popovnakova M, Tkacova R. Effects of continuous positive airway pressure on cardiovascular risk profile in patients with severe obstructive sleep apnea and metabolic syndrome. Chest 2008;134:686-92.
62. Zimmet P, Magliano D, Matsuzawa Y, Alberti G, Shaw J. The metabolic syndrome: a global public health problem and a new definition. J Atheroscler Thromb 2005;12:295-300.
63. Grundy SM. A constellation of complications: the metabolic syndrome. Clin Cornerstone 2005;7:36-45.
64. Alexander CM. The coming of age of the metabolic syndrome. Diabetes Care 2003;26:3180-1.
65. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002;287:356-9.
66. Ford ES. Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the U.S. Diabetes Care 2005;28:2745-9.
67. Grundy SM. Metabolic syndrome scientific statement by the American Heart Association and the National Heart, Lung, and Blood Institute. Arterioscler Thromb Vasc Biol 2005;25:2243-4.
68. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005;112:2735-52.
69. Reilly DF, Westgate EJ, FitzGerald GA. Peripheral circadian clocks in the vasculature. Arterioscler Thromb Vasc Biol 2007;27:1694-705.
70. Ivanov PC, Hu K, Hilton MF, Shea SA, Stanley HE. Endogenous circadian rhythm in human motor activity uncoupled from circadian influences on cardiac dynamics. Proc Natl Acad Sci U S A 2007;104:20702-7.
71. Kario K, Pickering TG, Matsuo T, Hoshide S, Schwartz JE, Shimada K. Stroke prognosis and abnormal nocturnal blood pressure falls in older hypertensives. Hypertension 2001;38:852-7.
72. Punjabi NM, Sorkin JD, Katzel LI, Goldberg AP, Schwartz AR, Smith PL. Sleep-disordered breathing and insulin resistance in middle-aged and overweight men. Am J Respir Crit Care Med 2002;165:677-82.
73. Kushida CA, Efron B, Guilleminault C. A predictive morphometric model for the obstructive sleep apnea syndrome. Ann Intern Med 1997;127:581-7.
74. Peppard PE, Young T, Palta M, Dempsey J, Skatrud J. Longitudinal study of moderate weight change and sleep-disordered breathing. JAMA 2000;284:3015-21.
75. Coughlin SR, Mawdsley L, Mugarza JA, Calverley PM, Wilding JP. Obstructive sleep apnoea is independently associated with an increased prevalence of metabolic syndrome. Eur Heart J 2004;25:735-41.
76. Vgontzas AN, Papanicolaou DA, Bixler EO, Hopper K, Lotsikas A, Lin HM et al. Sleep apnea and daytime sleepiness and fatigue: relation to visceral obesity, insulin resistance, and hypercytokinemia. J Clin Endocrinol Metab 2000;85:1151-8.
77. Marcus DM, Lynn J, Miller JJ, Chaudhary O, Thomas D, Chaudhary B. Sleep disorders: a risk factor for pseudotumor cerebri? J Neuroophthalmol 2001;21:121-3.
78. Lavie P, Herer P, Hoffstein V. Obstructive sleep apnoea syndrome as a risk factor for hypertension: population study. BMJ 2000;320:479-82.
79. Fletcher EC. The relationship between systemic hypertension and obstructive sleep apnea: facts and theory. Am J Med 1995;98:118-28.
80. Peppard PE, Young T, Palta M, Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 2000;342:1378-84.
81. Nieto FJ, Young TB, Lind BK, Shahar E, Samet JM, Redline S et al. Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study. JAMA 2000;283:1829-36.
82. Mayer J, Becker H, Brandenburg U, Penzel T, Peter JH, von Wichert P. Blood pressure and sleep apnea: results of long-term nasal continuous positive airway pressure therapy. Cardiology 1991;79:84-92.
83. Harris MI. Diabetes in America: epidemiology and scope of the problem. Diabetes Care 1998;21(Suppl 3):C11-C4.
84. Punjabi NM, Polotsky VY. Disorders of glucose metabolism in sleep apnea. J Appl Physiol 2005;99:1998-2007.
85. Punjabi NM, Ahmed MM, Polotsky VY, Beamer BA, O'Donnell CP. Sleep-disordered breathing, glucose intolerance, and insulin resistance. Respir Physiol Neurobiol 2003;136:167-78.
86. Punjabi NM, Shahar E, Redline S, Gottlieb DJ, Givelber R, Resnick HE. Sleep-disordered breathing, glucose intolerance, and insulin resistance: the Sleep Heart Health Study. Am J Epidemiol 2004;160:521-30.
87. Ayas NT, White DP, Al Delaimy WK, Manson JE, Stampfer MJ, Speizer FE et al. A prospective study of self-reported sleep duration and incident diabetes in women. Diabetes Care 2003;26:380-4.
88. Gottlieb DJ, Punjabi NM, Newman AB, Resnick HE, Redline S, Baldwin CM et al. Association of sleep time with diabetes mellitus and impaired glucose tolerance. Arch Intern Med 2005;165:863-7.
89. Sanders MH, Givelber R. Sleep disordered breathing may not be an independent risk factor for diabetes, but diabetes may contribute to the occurrence of periodic breathing in sleep. Sleep Med 2003;4:349-50.
90. Jean-Louis G, Kripke DF, Ancoli-Israel S, Klauber M, Sepulveda RS. Sleep duration, illumination, and activity patterns in a population sample: Effects of gender and ethnicity. Biol Psychiatry 2000;47:921-7.
91. Jean-Louis G, Kripke DF, Ancoli-Israel S. Sleep and quality of well-being. Sleep 2000;23:1115-21.
92. Kripke DF, Garfinkel L, Wingard DL, Klauber MR, Marler MR. Mortality associated with sleep duration and insomnia. Arch Gen Psychiatry 2002;59:131-6.
93. Stamler J, Wentworth D, Neaton JD. Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screens of the Multiple Risk Factor Intervention Trial (MRFIT). JAMA 1986;256:2823-8.
94. Goff DC Jr, D'Agostino RB Jr, Haffner SM, Otvos JD. Insulin resistance and adiposity influence lipoprotein size and subclass concentrations. Results from the Insulin Resistance Atherosclerosis Study. Metabolism 2005;54:264-70.
95. O'Meara JG, Kardia SL, Armon JJ, Brown CA, Boerwinkle E, Turner ST. Ethnic and sex differences in the prevalence, treatment, and control of dyslipidemia among hypertensive adults in the GENOA study. Arch Intern Med 2004;164:1313-8.
96. Zgierska A, Gorecka D, Radzikowska M, Baranowska B, Plywaczewski R, Bednarek M et al. Obstructive sleep apnea and risk factors for coronary artery disease. Pneumonol Alergol Pol 2000;68:238-46.
97. Tan KC, Chow WS, Lam JC, Lam B, Wong WK, Tam S et al. HDL dysfunction in obstructive sleep apnea. Atherosclerosis 2006;184:377-82.
98. Borgel J, Sanner BM, Bittlinsky A, Keskin F, Bartels NK, Buechner N et al. Obstructive sleep apnoea and its therapy influence high-density lipoprotein cholesterol serum levels. Eur Respir J 2006;27:121-7.
99. Cuhadaroglu C, Utkusavas A, Ozturk L, Salman S, Ece T. Effects of nasal CPAP treatment on insulin resistance, lipid profile, and plasma leptin in sleep apnea. Lung 2009;187:75-81.
100. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001;285:2486-97.